Imidazoline receptors: new targets for antihyperglycaemic drugs. (Q36181333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Imidazoline receptors: new targets for antihyperglycaemic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Morgan NG

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

575-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

'Seeing through a glass darkly': casting light on imidazoline 'I' sites.

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Characterization of a partial cDNA clone detected by imidazoline receptor-selective antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

The elusive family of imidazoline binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Imidazoline receptors and their endogenous ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Localization of I2-imidazoline binding sites on monoamine oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Initial phase II clinical studies on midaglizole (DG-5128). A new hypoglycemic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Phentolamine block of KATP channels is mediated by Kir6.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

BTS 67 582 stimulates insulin secretion from perifused rat pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Insulin-releasing action of the novel antidiabetic agent BTS 67 582.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Glucose-lowering effect of BTS 67 582.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

RX871024 induces Ca2+ mobilization from thapsigargin-sensitive stores in mouse pancreatic beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Selective imidazoline receptor agonists for metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Molecular and physiological properties of clonidine-displacing substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Agmatine: an endogenous clonidine-displacing substance in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Isolation and partial structure determination of a clonidine-displacing substance from bovine lung and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

Insulin Secretagogues with an Imidazoline Structure Inhibit Arginine-Induced Glucagon Secretion from Isolated Rat Islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.5.575

21 January 2018

Identifiers

DOI

10.1517/13543784.8.5.575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15992117%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference